OpenURL Connection Search

Select item for more details and to access through your institution.

Fully automated synthesis of [18F]fluoro-dihydrotestosterone ([18F]FDHT) using the FlexLab module.
Published in:
2016
By:
- Ackermann, Uwe;
- Lewis, Jason S.;
- Young, Kenneth;
- Morris, Michael J.;
- Weickhardt, Andrew;
- Davis, Ian D.;
- Scott, Andrew M.
Publication type:
Other
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03952-y
By:
- Chionh, Fiona;
- Gebski, Val;
- Al-Obaidi, Sheren J.;
- Mooi, Jennifer K.;
- Bruhn, Maressa A.;
- Lee, Chee K.;
- Chüeh, Anderly C.;
- Williams, David S.;
- Weickhardt, Andrew J.;
- Wilson, Kate;
- Scott, Andrew M.;
- Simes, John;
- Hardingham, Jennifer E.;
- Price, Timothy J.;
- Mariadason, John M.;
- Tebbutt, Niall C.
Publication type:
Article
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT).
Published in:
Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 580, doi. 10.1016/j.clgc.2024.01.013
By:
- Pemberton, Lara;
- Allen, Connor;
- Handel, Eleanor;
- Weickhardt, Andrew;
- Shapiro, Jeremy;
- Tran, Ben;
- Taylor, Renea A.;
- Risbridger, Gail P.;
- Pook, David W.
Publication type:
Article
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.
Published in:
Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 642, doi. 10.1111/ajco.13732
By:
- Chazan, Grace;
- Anton, Angelyn;
- Wong, Shirley;
- Shapiro, Julia;
- Weickhardt, Andrew;
- Azad, Arun;
- Kwan, Edmond M;
- Spain, Lavinia;
- Gunjur, Ashray;
- Torres, Javier;
- Parente, Phillip;
- Parnis, Francis;
- Goh, Jeffrey;
- Gibbs, Peter;
- Tran, Ben
Publication type:
Article
Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease.
Published in:
Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 1, p. 36, doi. 10.1111/ajco.13447
By:
- Schmidt, Andrew;
- Anton, Angelyn;
- Shapiro, Julia;
- Wong, Shirley;
- Azad, Arun;
- Kwan, Edmond;
- Spain, Lavinia;
- Muthusamy, Arun;
- Torres, Javier;
- Parente, Phillip;
- Parnis, Francis;
- Goh, Jeffrey;
- Joshua, Anthony M.;
- Pook, David;
- Gibbs, Peter;
- Tran, Ben;
- Weickhardt, Andrew
Publication type:
Article
Treatment selection for first‐line metastatic renal cell carcinoma in Australia: Impact of new therapy options.
Published in:
Asia Pacific Journal of Clinical Oncology, 2019, v. 15, p. 3, doi. 10.1111/ajco.13289
By:
- Schmidt, Andrew;
- Azad, Arun;
- Goh, Jeffrey;
- Harris, Carole;
- Joshua, Anthony M.;
- Weickhardt, Andrew;
- Krieger, Laurence
Publication type:
Article
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.
Published in:
Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 5, p. e97, doi. 10.1111/ajco.13109
By:
- Ha, Francis J.;
- Spain, Lavinia;
- Dowling, Anthony;
- Kwan, Edmond M.;
- Pezaro, Carmel;
- Day, Daphne;
- Chia, Puey Ling;
- Tran, Ben;
- Pook, David;
- Weickhardt, Andrew J.
Publication type:
Article
Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose‐reduced 3‐weekly docetaxel for metastatic castration‐resistant prostate cancer.
Published in:
Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 5, p. e399, doi. 10.1111/ajco.12840
By:
- Hamid, Anis A.;
- Willson, Kaspar;
- Tamjid, Babak;
- Campbell, Ainsley;
- Stewart, Josephine;
- Weickhardt, Andrew J.;
- Vincent, Andrew D.;
- Lee, Margaret;
- Pezaro, Carmel;
- Bergin, Alice;
- Tran, Ben;
- Gan, Chun
Publication type:
Article
Comparison of radiologically inserted arm ports versus surgically placed chest ports for chemotherapy.
Published in:
Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 3, p. 181, doi. 10.1111/j.1743-7563.2009.01231.x
By:
- WEICKHARDT, Andrew;
- JOSEPH, Timothy;
- SHEA, Susan;
- ARHANGHELSCHI, Dan;
- LOWE, Andrew;
- HAMILTON, Kate;
- CHONG, Geoff
Publication type:
Article
Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors.
Published in:
2018
By:
- Camidge, D. Ross;
- Sequist, Lecia V.;
- Jänne, Pasi A.;
- Weickhardt, Andrew J.;
- Dowling, Elizabeth S.;
- Alicea, Jeanette;
- Jean Fan;
- Oxnard, Geoffrey R.;
- Fan, Jean
Publication type:
journal article
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.
Published in:
JAMA Network Open, 2022, v. 5, n. 6, p. e2216379, doi. 10.1001/jamanetworkopen.2022.16379
By:
- Navani, Vishal;
- Ernst, Matthew;
- Wells, J. Connor;
- Yuasa, Takeshi;
- Takemura, Kosuke;
- Donskov, Frede;
- Basappa, Naveen S.;
- Schmidt, Andrew;
- Pal, Sumanta K.;
- Meza, Luis;
- Wood, Lori A.;
- Ernst, D. Scott;
- Szabados, Bernadett;
- Powles, Thomas;
- McKay, Rana R.;
- Weickhardt, Andrew;
- Suarez, Cristina;
- Kapoor, Anil;
- Lee, Jae Lyun;
- Choueiri, Toni K.
Publication type:
Article
Narrative review of inpatient nutritional management of anorexia nervosa with management recommendations for Australian tertiary health services.
Published in:
Internal Medicine Journal, 2023, v. 53, n. 10, p. 1752, doi. 10.1111/imj.15958
By:
- Hoo, Phoebe;
- Goldschlager, Romi;
- Katsoulis, John;
- Newnham, Evan;
- Harun, Nur‐Shirin;
- Gwee, Karen;
- Silberberg, Carol;
- Russell, Nick;
- Lam, Simon;
- Adithama, Esti;
- Cook, Natasha;
- Weickhardt, Andrew
Publication type:
Article
Changes in prescribing habits for the treatment of metastatic renal clear cell carcinoma (mRCC) in Australia.
Published in:
Internal Medicine Journal, 2021, v. 51, n. 7, p. 1173, doi. 10.1111/imj.15419
By:
- Balasubramanian, Adithya;
- Qu, Liang;
- Weickhardt, Andrew;
- Bolton, Damien;
- Perera, Marlon
Publication type:
Article
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.
Published in:
British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 764, doi. 10.1111/bcp.13488
By:
- Nebot, Noelia;
- Arkenau, Hendrik‐Tobias;
- Infante, Jeffrey R.;
- Chandler, Jason C.;
- Weickhardt, Andrew;
- Lickliter, Jason D.;
- Sarantopoulos, John;
- Gordon, Michael S.;
- Mak, Gabriel;
- St‐Pierre, Annie;
- Tang, Lihua;
- Mookerjee, Bijoyesh;
- Carson, Stanley W.;
- Hayes, Siobhan;
- Grossmann, Kenneth F.
Publication type:
Article
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
Published in:
Molecular Oncology, 2017, v. 11, n. 9, p. 1130, doi. 10.1002/1878-0261.12078
By:
- Yeung, Yvonne;
- Lau, David K.;
- Chionh, Fiona;
- Tran, Hoanh;
- Tse, Janson W. T.;
- Weickhardt, Andrew J.;
- Nikfarjam, Mehrdad;
- Scott, Andrew M.;
- Tebbutt, Niall C.;
- Mariadason, John M.
Publication type:
Article
Survival and functional outcomes of patients with metastatic solid organ cancer admitted to the intensive care unit of a tertiary centre.
Published in:
Critical Care & Resuscitation, 2017, v. 19, n. 2, p. 159, doi. 10.1016/s1441-2772(23)00788-3
By:
- Ha, Francis J.;
- Weickhardt, Andrew J.;
- Parakh, Sagun;
- Vincent, Andrew D.;
- Glassford, Neil J.;
- Warrillow, Stephen;
- Jones, Daryl
Publication type:
Article
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
Published in:
Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00570-x
By:
- Tremblay, Samuel;
- Alhogbani, Mofarej;
- Weickhardt, Andrew;
- Davis, Ian D;
- Scott, Andrew M;
- Hicks, Rodney J;
- Metser, Ur;
- Chua, Sue;
- Davda, Reena;
- Punwani, Shonit;
- Payne, Heather;
- Tunariu, Nina;
- Ho, Bao;
- Young, Sympascho;
- Singbo, Mahukpe Narcisse Ulrich;
- Bauman, Glenn;
- Emmett, Louise;
- Pouliot, Frédéric
Publication type:
Article
Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer.
Published in:
BJUI Compass, 2022, v. 3, n. 3, p. 205, doi. 10.1002/bco2.129
By:
- Anton, Angelyn;
- Pillai, Sruti;
- Semira, Marie Christine;
- Wong, Shirley;
- Shapiro, Julia;
- Weickhardt, Andrew;
- Azad, Arun;
- Kwan, Edmond M.;
- Spain, Lavinia;
- Gunjur, Ashray;
- Torres, Javier;
- Parente, Phillip;
- Parnis, Francis;
- Goh, Jeffrey;
- Baenziger, Olivia;
- Gibbs, Peter;
- Tran, Ben
Publication type:
Article
The contribution of multiparametric pelvic & whole body MR to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.225185
By:
- Ur Metser;
- Sue Chua;
- Bao Ho;
- Punwani, Shonit;
- Johnston, Edward;
- Pouliot, Frederic;
- Noam Tau;
- Hawsawy, Asmaa;
- Anconina, Reut;
- Bauman, Glenn;
- Hicks, Rodney J.;
- Weickhardt, Andrew;
- Ian D. Davis, Ian D.;
- Pond, Greg;
- Scott, Andrew M.;
- Tunariu, Nina;
- Sidhu, Harbir;
- Emmett, Louise
Publication type:
Article
Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220111
By:
- Kramer, Gerbrand M.;
- Yaqub, Maqsood;
- Vargas, Herbert A.;
- Schuit, Robert C.;
- Windhorst, Albert D.;
- van den Eertwegh, Alfonsus J. M.;
- van der Veldt, Astrid A. M.;
- Bergman, Andries M.;
- Burnazi, Eva M.;
- Lewis, Jason S.;
- Sua Chua;
- Staton, Kevin D.;
- Beattie, Brad J.;
- Humm, John L.;
- Davis, Ian D.;
- Weickhardt, Andrew J.;
- Scott, Andrew M.;
- Morris, Michael J.;
- Hoekstra, Otto S.;
- Lammertsma, Adriaan A.
Publication type:
Article
The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of 18F-Fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1253, doi. 10.2967/jnumed.118.225185
By:
- Metser, Ur;
- Chua, Sue;
- Bao Ho;
- Punwani, Shonit;
- Johnston, Edward;
- Pouliot, Frederic;
- Tau, Noam;
- Hawsawy, Asmaa;
- Anconina, Reut;
- Bauman, Glenn;
- Hicks, Rodney J.;
- Weickhardt, Andrew;
- Davis, Ian D.;
- Pond, Greg;
- Scott, Andrew M.;
- Tunariu, Nina;
- Sidhu, Harbir;
- Emmett, Louise
Publication type:
Article
Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1221, doi. 10.2967/jnumed.118.220111
By:
- Kramer, Gerbrand M.;
- Yaqub, Maqsood;
- Vargas, Herbert A.;
- Schuit, Robert C.;
- Windhorst, Albert D.;
- van den Eertwegh, Alfonsus J. M.;
- van der Veldt, Astrid A. M.;
- Bergman, Andries M.;
- Burnazi, Eva M.;
- Lewis, Jason S.;
- Sua Chua;
- Staton, Kevin D.;
- Beattie, Brad J.;
- Humm, John L.;
- Davis, Ian D.;
- Weickhardt, Andrew J.;
- Scott, Andrew M.;
- Morris, Michael J.;
- Hoekstra, Otto S.;
- Lammertsma, Adriaan A.
Publication type:
Article
Prospective, Multisite, International Comparison of 18F-Fluoromethylcholine PET/CT, Multiparametric MRI, and 68Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 6, p. 794, doi. 10.2967/jnumed.118.220103
By:
- Emmett, Louise;
- Metser, Ur;
- Bauman, Glenn;
- Hicks, Rodney J.;
- Weickhardt, Andrew;
- Davis, Ian D.;
- Punwani, Shonit;
- Pond, Greg;
- Chua, Sue;
- Ho, Bao;
- Johnston, Edward;
- Pouliot, Frederic;
- Scott, Andrew M.
Publication type:
Article
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
Published in:
Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 1516, doi. 10.2967/jnumed.117.206490
By:
- Vargas, Hebert Alberto;
- Kramer, Gem M.;
- Scott, Andrew M.;
- Weickhardt, Andrew;
- Meier, Andreas A.;
- Parada, Nicole;
- Beattie, Bradley J.;
- Humm, John L.;
- Staton, Kevin D.;
- Zanzonico, Pat B.;
- Lyashchenko, Serge K.;
- Lewis, Jason S.;
- Yaqub, Maqsood;
- Sosa, Ramon E.;
- van den Eertwegh, Alfons J.;
- Davis, Ian D.;
- Ackermann, Uwe;
- Pathmaraj, Kunthi;
- Schuit, Robert C.;
- Windhorst, Albert D.
Publication type:
Article
Prostate‐specific membrane antigen positron emission tomography‐computed tomography use prior to systemic therapy in metastatic castration‐resistant prostate cancer.
Published in:
BJU International, 2023, v. 131, n. 2, p. 179, doi. 10.1111/bju.15930
By:
- Kelly, Richard;
- Jensen, Andrew;
- Karunaratna, Nathasha;
- Wong, Shirley;
- Shapiro, Julia;
- Weickhardt, Andrew;
- Parente, Phillip;
- Azad, Arun A.;
- Uccellini, Anthony;
- Torres, Javier;
- Parnis, Francis;
- Goh, Jeffrey;
- Kwan, Edmond M.;
- Brown, Stephen;
- Steer, Christopher;
- Warren, Mark;
- Gibbs, Peter;
- Tran, Ben;
- Anton, Angelyn
Publication type:
Article
High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres.
Published in:
BJU International, 2022, v. 130, p. 5, doi. 10.1111/bju.15648
By:
- Connolly, Elizabeth A.;
- Weickhardt, Andrew;
- Grimison, Peter;
- Asher, Rebecca;
- Heller, Gillian Z.;
- Lewin, Jeremy;
- Liow, Elizabeth;
- Toner, Guy;
- Tung, Iris L.Y.;
- Tran, Ben;
- Hill, Sean;
- Walpole, Euan;
- McKenzie, Jane;
- Kuchel, Anna;
- Goh, Jeffrey;
- Forgeson, Garry;
- Tan, Alvin;
- Joshi, Abhishek;
- Wickham, Alistair;
- Tan, Hsiang
Publication type:
Article
Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer.
Published in:
BJU International, 2021, v. 128, p. 18, doi. 10.1111/bju.15364
By:
- Kelly, Richard;
- Anton, Angelyn;
- Wong, Shirley;
- Shapiro, Julia;
- Weickhardt, Andrew;
- Azad, Arun;
- Kwan, Edmond Michael;
- Spain, Lavinia;
- Muthusamy, Arun;
- Torres, Javier;
- Parente, Phillip;
- Parnis, Francis;
- Goh, Jeffrey;
- Joshua, Anthony;
- Pook, David;
- Baenziger, Olivia;
- Gibbs, Peter;
- Tran, Ben
Publication type:
Article
Radiotherapy and immunotherapy: a synergistic effect in cancer care.
Published in:
2019
By:
- Turgeon, Guy‐Anne;
- Weickhardt, Andrew;
- Azad, Arun A;
- Solomon, Benjamin;
- Siva, Shankar;
- Turgeon, Guy-Anne
Publication type:
journal article
Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.
Published in:
World Journal of Urology, 2022, v. 40, n. 5, p. 1111, doi. 10.1007/s00345-021-03908-x
By:
- Balasubramanian, Adithya;
- Gunjur, Ashray;
- Weickhardt, Andrew;
- Papa, Nathan;
- Bolton, Damien;
- Lawrentschuk, Nathan;
- Perera, Marlon
Publication type:
Article
Pancreatic mass in a patient undergoing immunotherapy for metastatic renal cell carcinoma: dilemmas in management.
Published in:
ANZ Journal of Surgery, 2022, v. 92, n. 7, p. 1899, doi. 10.1111/ans.17363
By:
- Goh, Su Kah;
- Cox, Daniel R. A.;
- Weickhardt, Andrew;
- Muralidharan, Vijayaragavan;
- Perini, Marcos V.
Publication type:
Article
Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.
Published in:
Cancer (0008543X), 2014, v. 120, n. 5, p. 664, doi. 10.1002/cncr.28478
By:
- Brosnan, Evelyn M.;
- Weickhardt, Andrew J.;
- Lu, Xian;
- Maxon, Delee A.;
- Barón, Anna E.;
- Chonchol, Michel;
- Camidge, D. Ross
Publication type:
Article
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
Published in:
Cancer (0008543X), 2013, v. 119, n. 13, p. 2383, doi. 10.1002/cncr.28089
By:
- Weickhardt, Andrew J.;
- Doebele, Robert C.;
- Purcell, W. Thomas;
- Bunn, Paul A.;
- Oton, Ana B.;
- Rothman, Micol S.;
- Wierman, Margaret E.;
- Mok, Tony;
- Popat, Sanjay;
- Bauman, Julie;
- Nieva, Jorge;
- Novello, Silvia;
- Ou, Sai‐Hong Ignatius;
- Camidge, D. Ross
Publication type:
Article
Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.
Published in:
Cancer (0008543X), 2013, v. 119, n. 8, p. 1467, doi. 10.1002/cncr.27913
By:
- Weickhardt, Andrew J.;
- Aisner, Dara L.;
- Franklin, Wilbur A.;
- Varella‐Garcia, Marileila;
- Doebele, Robert C.;
- Camidge, D. Ross
Publication type:
Article
Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer.
Published in:
Cancer (0008543X), 2012, v. 118, n. 21, p. 5302, doi. 10.1002/cncr.27450
By:
- Weickhardt, Andrew J.;
- Rothman, Micol S.;
- Salian-Mehta, Smita;
- Kiseljak-Vassiliades, Katja;
- Oton, Ana B.;
- Doebele, Robert C.;
- Wierman, Margaret E.;
- Camidge, D. Ross
Publication type:
Article
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
Published in:
Cancer (0008543X), 2012, v. 118, n. 18, p. 4502, doi. 10.1002/cncr.27409
By:
- Doebele, Robert C.;
- Lu, Xian;
- Sumey, Christopher;
- Maxson, DeLee A.;
- Weickhardt, Andrew J.;
- Oton, Ana B.;
- Bunn, Paul A.;
- Barón, Anna E.;
- Franklin, Wilbur A.;
- Aisner, Dara L.;
- Varella-Garcia, Marileila;
- Camidge, D. Ross
Publication type:
Article
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.
Published in:
2022
By:
- Weickhardt, Andrew J.;
- Lau, David K.;
- Hodgson-Garms, Margeaux;
- Lavis, Austen;
- Jenkins, Laura J.;
- Vukelic, Natalia;
- Ioannidis, Paul;
- Luk, Ian Y.;
- Mariadason, John M.
Publication type:
journal article
Oxaliplatin-Induced Neuropathy in Colorectal Cancer.
Published in:
Journal of Oncology, 2011, p. 1, doi. 10.1155/2011/201593
By:
- Weickhardt, Andrew;
- Wells, Keith;
- Messersmith, Wells
Publication type:
Article
Hypocalcaemia following denosumab in prostate cancer: A clinical review.
Published in:
Clinical Endocrinology, 2020, v. 92, n. 6, p. 495, doi. 10.1111/cen.14169
By:
- Lau, Lik‐Hui;
- Cliff, Edward R.S.;
- Wong, Vanessa;
- Wong, Henry;
- Torkamani, Niloufar;
- Eer, Audrey;
- Weickhardt, Andrew;
- Grossmann, Mathis
Publication type:
Article

Found: 38

Fully automated synthesis of [<sup>18</sup>F]fluoro-dihydrotestosterone ([<sup>18</sup>F]FDHT) using the FlexLab module.

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.

Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT).

Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.

Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease.

Treatment selection for first‐line metastatic renal cell carcinoma in Australia: Impact of new therapy options.

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.

Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose‐reduced 3‐weekly docetaxel for metastatic castration‐resistant prostate cancer.

Comparison of radiologically inserted arm ports versus surgically placed chest ports for chemotherapy.

Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors.

Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.

Narrative review of inpatient nutritional management of anorexia nervosa with management recommendations for Australian tertiary health services.

Changes in prescribing habits for the treatment of metastatic renal clear cell carcinoma (mRCC) in Australia.

Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.

K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.

Survival and functional outcomes of patients with metastatic solid organ cancer admitted to the intensive care unit of a tertiary centre.

Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.

Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer.

The contribution of multiparametric pelvic & whole body MR to interpretation of <sup>18</sup>F-fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.

Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.

The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of <sup>18</sup>F-Fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.

Assessment of Simplified Methods for Quantification of <sup>18</sup>F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.

Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes

Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.

Prostate‐specific membrane antigen positron emission tomography‐computed tomography use prior to systemic therapy in metastatic castration‐resistant prostate cancer.

High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres.

Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer.

Radiotherapy and immunotherapy: a synergistic effect in cancer care.

Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.

Pancreatic mass in a patient undergoing immunotherapy for metastatic renal cell carcinoma: dilemmas in management.

Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.

Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.

Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer.

Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.

Oxaliplatin-Induced Neuropathy in Colorectal Cancer.

Hypocalcaemia following denosumab in prostate cancer: A clinical review.